Steroid jabs for hip arthritis may risk bones

Image
ANI Washington D.C. [USA]
Last Updated : Nov 30 2017 | 2:45 PM IST

According to a recent study, those steroid injections may be putting hip arthritis patients' bones at risk.

Receiving an injection of a steroid and anesthetic is a common treatment for patients who are experiencing pain and inflammation in a joint, such as the hip, knee or shoulder.

Study author Connie Y. Chang from Harvard Medical School in Boston said that changes due to osteoarthritis, such as narrowing in the space between joints and the development of bony proliferations, typically develop slowly over time.

When reading follow-up radiographs of patients who had received the hip injections, the team noticed changes had developed rapidly in some of them.

Chang noted that patients receiving hip injections have symptoms of hip pain severe enough to require the injection and may be prone to faster progression of bony changes compared to the control groups.

To determine whether arthritis worsened in patients following a hip steroid/anesthetic injection, the team analysed 102 patients with age ranging from 19-92, including 62 women, who received X-ray images of the treated hip at the time of the injection and during a follow-up three to nine months later.

Two musculoskeletal radiologists independently reviewed the X-ray images of the patients who received the injections and those of two control groups matched to demographics and follow-up imaging duration.

They observed bone collapse in the head of the femur bone, located at the top of the femur at the articulation with the pelvic bone, in 15-17 percent of hip injection patients, versus four percent of hip control patients and two percent of shoulder control patients.

These considerations may be important as some orthopedists are requesting higher steroid doses and injections in younger patients.

The research is presented at the annual meeting of the Radiological Society of North America (RSNA).

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 30 2017 | 2:45 PM IST

Next Story